SPOTLIGHT -
Opinion
Video
Author(s):
The Psychiatric Times editor-in-chief shares perspectives on how a novel treatment, MDMA-assisted therapy, can potentially change the treatment landscape and improve patients’ lives.
Transneural Therapeutics: A New Company to Develop Novel Neuroplastogens
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
After the Wildfires: Reflections on Positive Psychiatry and Posttraumatic Growth
Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety
What Went Wrong? Top 6 Clinical Disappointments
Panel Shares Top 7 Insights Into Addressing PTSD